Literature DB >> 8837066

Central nervous system distribution of fibroblast growth factor injected into the blood stream.

P Cuevas1, A Fernández-Ayerdi, F Carceller, S Colin, F Mascarelli, I Muñoz-Willery, G Giménez-Gallego.   

Abstract

It has been shown that fibroblast growth factors (FGFs) protect hypocampal CAI cells from the effects of transient ischemia when injected either intraventrically or intravenously. The effectiveness of the systemic treatment seems to suggest that FGFs cross the blood-brain barrier to some extent. The appearance of basic fibroblast growth factor (bFGF) in the rat central nervous system after systemic administration have been autoradiographically examined using a 14C uniformly labeled preparation. Our results show that, two hours after a systemic bolus administration, bFGF spots in several populations of neuronal and in non-neural cells except in glial cells. Label accumulation was imperceptible when either 14C-bFGF was heated previously to the systemic injection or was co-administered with an excess of unlabeled bFGF. Our results indicate the existence of a saturable transport system of FGFs across the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8837066     DOI: 10.1080/01616412.1996.11740418

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  8 in total

Review 1.  Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier.

Authors:  Michelle A Erickson; Kenji Dohi; William A Banks
Journal:  Neuroimmunomodulation       Date:  2012-01-11       Impact factor: 2.492

2.  Interaction between cholecystokinin and the fibroblast growth factor system in the ventral tegmental area of selectively bred high- and low-responder rats.

Authors:  S J Ballaz; J Perez; M Waselus; H Akil; S J Watson
Journal:  Neuroscience       Date:  2013-10-09       Impact factor: 3.590

Review 3.  Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.

Authors:  Michelle A Erickson; William A Banks
Journal:  Pharmacol Rev       Date:  2018-04       Impact factor: 25.468

Review 4.  Pharmacological enhancement of fear reduction: preclinical models.

Authors:  Bronwyn M Graham; Julia M Langton; Rick Richardson
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

5.  Blood-brain barrier transport of 125I-labeled basic fibroblast growth factor.

Authors:  Y Deguchi; T Naito; T Yuge; A Furukawa; S Yamada; W M Pardridge; R Kimura
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

Review 6.  The blood-brain barrier in neuroimmunology: Tales of separation and assimilation.

Authors:  W A Banks
Journal:  Brain Behav Immun       Date:  2014-08-27       Impact factor: 7.217

7.  A new role for FGF2 as an endogenous inhibitor of anxiety.

Authors:  Javier A Perez; Sarah M Clinton; Cortney A Turner; Stanley J Watson; Huda Akil
Journal:  J Neurosci       Date:  2009-05-13       Impact factor: 6.167

Review 8.  The blood-brain barrier as an endocrine tissue.

Authors:  William A Banks
Journal:  Nat Rev Endocrinol       Date:  2019-08       Impact factor: 43.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.